Limited global diversity of the Plasmodium vivax merozoite surface protein 4 gene
Introduction
Plasmodium vivax malaria is considered as the most neglected, highly prevalent, and potentially dangerous disease (Baird, 2007, Price et al., 2007). Currently, it is estimated that 2.6 billion people live at the risk of vivax malaria and there are 130–145 million vivax malaria cases per year (Hay et al., 2004, Guerra et al., 2006). Although rarely fatal, a P. vivax infection is by no means clinically benign, and the episode of debilitating intensity can be repeated several times due to relapses (Price et al., 2007). Recently, several prospective studies have reported that clinical and severe vivax malaria, manifested by severe anaemia, respiratory distress and impaired consciousness was common in hyperendemic areas of Asia and South America (Barcus et al., 2007, Rodriguez-Morales et al., 2008, Genton et al., 2008, Tjitra et al., 2008). Furthermore, the first-line therapies comprised of chloroquine and primaquine remain unchanged for the past 50 years, and the appearance of resistant parasites to these drugs are of great concern for vivax malaria control. As malaria eradication is once again on the agenda of international malaria control communities (Roberts and Enserink, 2007), these efforts must also include elimination of vivax malaria.
Effective control of malaria requires comprehensive approaches integrating multiple strategies such as chemotherapy, vaccination, and vector control. For vaccine development, antigens located on the surface or apical organelles of merozoites are prime candidates, given their potentials of eliciting immunity that blocks merozoite invasion of host erythrocytes (Richie and Saul, 2002). The effect of vertebrate host immunity on shaping the parasite population structure is well known and considered mostly responsible for the diverse antigenic repertoire of the parasite. There is strong evidence showing the induction of strain-specific protective immunity in human (e.g., Hodder et al., 2001, Cortes et al., 2005). Therefore, the significant levels of polymorphism present in these antigens create a major challenge for the development of a successful vaccine. Since the antigenic repertoire of a specific antigen is shaped by multiple factors such as the selection strength of host immune responses, functional constraints, and frequency of genetic recombination, detailed studies of antigenic diversity of a vaccine candidate in different malaria-endemic areas must be undertaken (Cui et al., 2003).
At least ten distinct P. vivax merozoite surface proteins (PvMSPs) have been identified experimentally or by in silico analysis of the P. vivax genome (Carlton et al., 2008). Among them, PvMSP4 shows significant homology to PfMSP4 in terms of sequence identity and gene structure (Black et al., 2002). In P. falciparum and P. vivax, MSP4 and MSP5 have similar gene organizations and are located in tandem on chromosome 2 and 4, respectively, suggesting that these two genes might have originated from an ancient gene duplication event. In rodent malaria parasites, a single gene MSP4/5 is found with similarity to both MSP4 and 5. The PvMSP4 gene has a two-exon structure, with a 300 bp exon 1 and 387 bp exon 2 separated by a 156 bp intron for the Thai-NYU strain. Like PfMSP4, PvMSP4 is a GPI-anchored surface protein with an epidermal growth factor (EGF)-like domain encoded in the second exon (Black et al., 2002).
PfMSP4 is being considered as a component of a subunit vaccine (Dooland and Steward, 2007). Immunization of mice with Plasmodium yoelii MSP4/5 is able to confer significant protection against lethal challenges with blood stage P. yoelii (Goschnick et al., 2004). Recombinant PfMSP4 protein is immunogenic in laboratory animals and recognized by antibodies from humans living in malaria endemic areas (Wang et al., 1999, Wang et al., 2001). Limited population studies indicate that PfMSP4 has low sequence diversity (Wang et al., 2002, Benet et al., 2004, Polson et al., 2005), and analysis of PvMSP4 sequences from 30 Colombian samples revealed a similar result of limited polymorphisms (Martinez et al., 2005). Yet, it is not clear whether this reflects a recent expansion of similar strains in this region or global conservation of the PvMSP4 locus. To determine whether this observation can be extended to other vivax endemic regions, we have sequenced 195 samples from several vivax endemic countries. Our analysis supports the finding that PvMSP4 has limited genetic diversity.
Section snippets
Source of P. vivax samples
We have procured 195 P. vivax finger-prick samples on filter papers from Thailand (n = 130), Indonesia (n = 34), Brazil (n = 24), India (n = 1), Papua New Guinea (n = 1), Solomon islands (n = 1), China (n = 2) and Vietnam (n = 2). This study was approved by the Institutional Review Board at Chulalongkorn University. Parasite genomic DNA was extracted by using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). The DNA purification procedure was essentially as described in the manufacturer's instruction manual
Genetic diversity of the PvMSP4
To assess the global genetic diversity of P. vivax parasites at the PvMSP4 locus, we determined the PvMSP4 sequence from 195 parasite clinical samples from various vivax malaria-endemic areas. Together with two PvMSP4 sequences from the Sal-1 and Thai-NYU strain, 53 haplotypes were identified (Table 1). Geographically, the 130 Thai, 34 Indonesian, and 24 Brazilian samples contained 35, 15, and 12 PvMSP4 haplotypes, respectively. Hyplotype 1, 3, and 5 were the most abundant and they accounted
Discussion
In this study, we have characterized the genetic diversity of PvMSP4 gene using 195 field samples representing diverse endemic areas of P. vivax parasite. Our results confirmed the previous finding about the conservation of this gene. Most of the observed haplotype diversity of PvMSP4 is due to polymorphism in repeat copy number of two repeat arrays. The overall nucleotide diversity of PvMSP4 is much lower than what has been determined for other P. vivax antigens such as MSP1 (Putaporntip et
Acknowledgements
We are grateful to all patients who donated their blood samples for this analysis. This work was supported by research grants from The National Research Council of Thailand and The Thai Government Research Budget to S.J. and C.P., a grant from The Thailand Research Fund (RMU5080002) to C.P. and a grant (D43-TW006571) from Fogarty International Center, National Institutes of Health to L.C.
References (42)
Neglect of Plasmodium vivax malaria
Trends Parasitol.
(2007)- et al.
Diversity of the Plasmodium falciparum vaccine candidate merozoite surface protein 4 (MSP4) in a natural population
Mol. Biochem. Parasitol.
(2004) - et al.
The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite
Mol. Biochem. Parasitol.
(2002) - et al.
Invasion of red blood cells by malaria parasites
Cell
(2006) - et al.
The genetic diversity of Plasmodium vivax populations
Trends Parasitol.
(2003) - et al.
Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes
Mol. Biochem. Parasitol.
(2000) - et al.
Mapping the global extent of malaria in 2005
Trends Parasitol.
(2006) - et al.
The global distribution and population at risk of malaria: past, present, and future
Lancet Infect. Dis.
(2004) - et al.
Contrasting genetic structure in Plasmodium vivax populations from Asia and South America
Int. J. Parasitol.
(2007) - et al.
Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax
Gene
(2008)
High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4)
Infect. Genet. Evol.
Gene polymorphism of Plasmodium falciparum merozoite surface proteins 4 and 5
Mol. Biochem. Parasitol.
Diversity in the thrombospondin-related adhesive protein gene (TRAP) of Plasmodium vivax
Gene
Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions
Infect. Genet. Evol.
Limited polymorphism of the vaccine candidate merozoite surface protein 4 of Plasmodium falciparum
Mol. Biochem. Parasitol.
Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua
Am. J. Trop. Med. Hyg.
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Nature
Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1
Infect. Immun.
Status of malaria vaccine R&D in 2007
Expert Rev. Vaccines
Arlequin ver. 3.0: an integrated software package for population genetics data analysis
Evol. Bioinfor.
Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia
J. Infect. Dis.
Cited by (17)
Structural diversity, natural selection and intragenic recombination in the Plasmodium vivax merozoite surface protein 9 locus in Thailand
2020, Infection, Genetics and EvolutionCitation Excerpt :However, the population structure of P. vivax observed in this study has suggested that population migration may not contribute enormously to malaria spread between endemic areas in Thailand. Our previous analyses on sequence diversity in the genes encoding major vaccine candidate antigens, e.g. pvmsp1, pvmsp3β, pvmsp4, pvmsp5, pvmsp7e, pvama1 and pvtrap have shown that P. vivax populations from endemic areas bordering Myanmar, i.e. Tak and Prachuap Khiri Khan Provinces, and those bordering Cambodia, i.e. Ubon Ratchathani and Chanthaburi Provinces, exhibited comparable sequence diversity that remarkably exceeded the population from Yala and Narathiwat Provinces bordering Malaysia (Jongwutiwes et al., 2010; Putaporntip et al., 2009a, 2009b, 2010, 2014; Kosuwin et al., 2014; Cheng et al., 2018). The low number of haplotypes and low level of haplotype diversity observed in pvmsp9 in P. vivax population from Yala and Narathiwat Provinces were in line with our previous reports in which P. vivax in both provinces could have been shaped by the effect of population bottleneck (Jongwutiwes et al., 2010; Putaporntip et al., 2014: Kosuwin et al., 2014; Cheng et al., 2018).
Malaria in the Greater Mekong Subregion: Heterogeneity and complexity
2012, Acta TropicaCitation Excerpt :In some southern provinces, such as Yala and Narathiwat where malaria was largely eliminated decades ago, it has recently reappeared with sporadic outbreaks occurring in several districts. Molecular population genetic studies revealed that the genetic structure of the parasites, in contrast to being panmictic in the west, is more clonal in the south and likely represents recent expansion of a limited number of parasite strains (Putaporntip et al., 2009a,b). In eastern areas of Thailand, such as Sa Kaeo Province, P. vivax has replaced the dominant status of falciparum malaria with its relative prevalence increasing from <25% before 1995 to almost 90% in recent years.
Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates
2011, Infection, Genetics and EvolutionCitation Excerpt :Several MSPs are highly polymorphic in the latter species (Figtree et al., 2000; Gomez et al., 2006; Mascorro et al., 2005), thus hampering vaccine development. However, other MSPs have displayed limited diversity (Martinez et al., 2005; Putaporntip et al., 2009), thereby making them attractive targets to be included in anti-malarial vaccines. msp-7 is a multigenic family, being MSP-7K (XM_001614090.1) the only encoded protein for which there is experimental evidence of its localization on the parasite surface in P. vivax (Mongui et al., 2006).
Bottleneck effects on vaccine-candidate antigen diversity of malaria parasites in Thailand
2010, VaccineCitation Excerpt :The complete nucleotide sequences of P. falciparum csp and msp-2 and of P. vivax msp-1, ama-1 and msp-4 were obtained by using respective forward and reverse primers for each gene as described previously [10,12,19,23,24]. Sequences of P. falciparum csp and msp-2 from the NW and of P. vivax ama-1, msp-4 and msp-5 from both NW and South were from our previous analyses [10,12,19,24]. The complete 128 nucleotide sequences of Pvmsp-1 were obtained following the methods as previously described [23].